CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 6, July 2012
AFRICA
317
Conclusion
There was a correlation between plasma homocysteine level and
myocardial perfusion indices for patients with scintigraphically
proven CAD but not in those patients without disease. We also
confirmed that homocysteine level may be an independent risk
factor for the presence of CAD, marking the extent of established
disease and a higher number of known risk factors. These
findings may help to explain why lowering high homocysteine
levels is clinically ineffective.
References
1.
Nasir K, Tsai M, Rosen BD, Fernandes V, Bluemake DA, Folsom AR,
et al
. Elevated homocysteine is associated with reduced regional left
ventricular function.
Circulation
2007;
115
: 180–187
.
2.
Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis from
basic science to clinical medicine.
Throm Haemost
2005;
94
: 907–915.
3.
Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B,
Ullmann D,
et al
. A prospective study of plasma homocysteine and and
risk for myocardial infarction in US physicians.
J Am Med Assoc
1992;
268
: 877–881.
4.
Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y,
et
al.
Prospective study for homocysteine and risk of ischaemic stroke
among patients with pre-existing coronary heart disease.
Stroke
2003;
34
: 632–636.
5.
Zylberstein DE, Bengstsson C, Bjorkelund C, Landass S, Sundh V,
Theille D,
et al.
Serum homocysteine in relation to mortality and
morbidity from coronary artery disease: a 24-year follow up of the
population study of the women in Gothenburg.
Circulation
2004;
109
:
601–606.
6.
de Bree , Vershuren VM, Blom HJ, Nadeau M, Trijbels FJ, Kromhout
D. Coronary artery disease mortality, plasma homocysteine, and B vita-
mins: a prospective study.
Atherosclerosis
2003;
166
: 369–377.
7.
Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith DG.
Homocysteine and coronary heart disease in the Caerpillay cohort: a
10-year follow up.
Heart
2001;
85
: 153–158.
8.
Clarke R, Hasley J, Lewington S, Lonn E, Armitage J, Manson JE,
et
al.
Effects of lowering homocysteine levels with B vitamins on cardio-
vascular disease, cancer, and cause specific mortality: Meta-analysis of
8 randomized trials involving 37 585 individuals.
Arch Int Med
2010;
170
: 1622–1631.
9.
Rossi GP, Seccia TM, Pessina AC. Homocysteine, left ventricular
dysfunction and coronary artery disease: is there a link?
Clin Chem Lab
Med
2007;
45
: 1645–1651.
10. Sasso FC, Rambaldi PF, Carbonara O, Nasti R, Torella M, Rotondo A,
et al.
Perspective of nuclear diagnostic imaging in diabetic cardiomyo-
pathy.
Nut Met Cardiovasc Dis
2010;
20
: 208–216.
11. Knollman D, Knebel I, Koch K-C, Gebhard M, Krohn T, Buell U,
Schaeffer WM,
et al
. Comparison of SSS and SRS calculated from
normal databases provided by QPS and 4D-MSPECT manufacturers
and identical institutional normal.
Eur J Nuc Med Mol Imaging
2008;
35
; 311–318.
12. Nexo E, Engbaek F, Ueland PM, Westby C, O’Gorman P, Johnson C,
et al
. Evaluation of novel assay in clinical chemistry: quantification of
plasma total homocysteine.
Clin Chem
2000;
46
: 1150–1156.
13. Cerquerria MD, Wiessman NJ, Dilsizian V, Jacobs Ak, Kaul S,
et al.
Standardized myocardial segmentation and nomenclature for tomo-
graphic imaging of the heart: A statement for healthcare profession-
als from the Cardiac Imaging Committee of the Council on Clinical
Cardiology of the American Heart Association.
Circulation
2002;
105
:
539–542.
14. Cragar M, Mahamoudian B, Ayetemir K, Kahraman S, Arc M, Kabakc
G,
et al
. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI)
gated SPECT for the detection of silent myocardial ischemia in hemodi-
alysis patients: clinical variables associated with abnormal test results.
Nuc Med Commum
2006;
27
: 61–69.
15. Flemming RM, Harrington GM. What is the relationship between
myocardial perfusion imaging and coronary artery disease risk factors
and markers of inflammation,
Angiology
2008;
59
: 16–25.
16. Guent-Rodriguez R-M, Juilliere Y, Nippert M, Abdelmouttaleb I.
Herbeth B, Aliot E,
et al
. Left ventricular systolic dysfynction is an
independent predictor of homocysteine in angiographically docu-
mented patients with and without coronary artery lesions.
J Thromb
Haemost
2007;
5
: 1209–1216.
17. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC,
Howard VD,
et al.
Lowering homocysteine in patients with ischemic
stroke to prevent recurrent stroke, myocardial infarction and death:
the vitamin Intervention for stroke prevention (VISP) randomized
controlled trial.
J Am Med Assoc
2004;
291
: 565–575.
18. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M,
et al.
Homocysteine lowering with folic acid and B vitamins in vascular
disease.
N Eng J Med
2006;
354
: 1567–1577.
19. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen
T,
et al.
Homocysteine lowering and cardiovascular events after acute
myocardial infarction.
N Eng J Med
2006;
354
: 1578–1588.
20. Rosenberger D, Gargoum R, Tyagi N, Metreveli N, Sen U, Maldonado
C,
et al.
Homocysteine enriched diet leads to prolonged QT interval
and reduced left ventricular performance in telemetric monitored
mice.
Nutr Metab Cardivasc Dis
2011;
2
1: 492–498. DOI:10.1016/
jnumcd.2009.11.014.
21. Okuyan E, Uslu A, Caker MA, Sahin I, Onur I, Enhos A,
et al.
Homocysteine levels in patients with preserved ejection fraction.
Cardiology
2010;
117
: 21–27.
22. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP,
et al.
Incremental value of prognostic testing in patients with known or
suspected ischaemic heart disease: a basis for optimum utilization of
exercise technetium-99m sestamibi myocardial perfusion single-photon
emission computed tomography.
J Am Coll Cardiol
1995;
26
: 639–647.
23. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT,
et
al.
Automatic quantification of ejection fraction from gated myocardial
perfusion SPECT.
J Nuc Med
1995;
36
: 2138–2147.
24. Germano G, Erel J, Lewin H, Kavangagh PB, Bermen DS. Automatic
quantitation of regional myocardial wall motion and thickening from
gated technetium-99m sestamibi myocardial single-photn emission
computered tomography.
J Nuc Med
1997;
30
: 1360–1367.
25. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C,
et al
. Homocysteine as a risk factor for coronary artery disease and its
association with inflammatory biomarkers, lipids and dietary factors.
Atherosclerosis
2004;
177
: 375–381.
26. Soinio M, Marniemi J, Lakso M, Lehto S, Ronnemaa T. Elevated
plasma homocysteine levels is an independent predictor of coronary
artery events in patients with type 2 diabetes mellitus.
Ann Intern Med
2004;
140
: 94–100.
27. Sutten-Tyrrel K, Bostom A, Sehlub J, Zeigler-Johnson C. High homo-
cysteine levels are independently related to Systolic hypertension in
older adults.
Circulation
1997;
96
: 1745–1749.
28. Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in
diabetes.
Biochem Soc Trans
2007;
35
: 1175–1179.
29. Rodrigo T, Wallter P, Araya J, Orellana M, Rivera G. Homocysteine and
essential hypertension.
J Clin Pharmacol
2003;
43
: 1299–1306.
30. Wald DS, Law M, Morris J. Serum homocysteine and the severity of
coronary artery disease.
Throm Res
2003;
111
: 55–57.
31. Barmpouletos D, Starvens G, Ahlberg AW, Katten DM, O’Sullivan DM,
Heller GV. Duration and type of therapy for diabetes: Impact on cardiac
risk stratification with stress electrocardiographic-gated SPECT perfu-
sion imaging.
J Nuc Cardiol
2010;
17
: 1041–1049.
32. Lin Y, Pao K, Yang W, Wu V, Chen Y, Lin Y,
et al.
Waist to hip ratio
correlates with homocysteine levels in males with coronary artery
disease.
Clin Chem Lab Med
2008;
46
: 125–130.
33. Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosendurg IH, Selhub
J. Determinants of total plasma homocysteine concentration in the
Framingham Offspring cohort.
Am J Clin Nutr
2001;
73
: 613–623.
34. Karatela Ra, Sainani GS. Plasma homocysteine, obese, overweight and
normal weight hypertensives and non hypertensives.
Indian Heart J.
2009;
61
: 156–159.
35. Ubbink JB, Vermark WJ, Bennet JM, van Staden DA, Bissbort S.
The prevalence of homocystenemia and hypercholesterolemia in
angiographically defined coronary artery disease.
J Mol Med
1991;
69
: 527–534.
